| Product Name | NebuSelect™ Recombinant Mouse PILRA, hFc-tag |
|---|---|
| Catalog Number | NBL-240978 |
| Alias/Synonyms | PILRA; PILRA; FDF03; PILRalpha; PILR-alpha |
| Appearance | see COA |
| Molecule Weight | Glu32-Val197 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | Q2YFS3-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-240978-100ug | 100ug | Inquire | Inquire | |
| NBL-240978-1mg | 1mg | Inquire | Inquire | |
| NBL-240978-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse PILRA, hFc-tag
Catalog#:
NBL-240978
Description:
NebuSelect™ Recombinant Mouse PILRA, hFc-tag(Cat#NBL-240978) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Glu32-Val197.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 45.4 kDa. Due to glycosylation, the protein migrates to 70-75 kDa based on Bis-Tris PAGE result.
Target Name:
PILRA; PILRA; FDF03; PILRalpha; PILR-alpha
Target Information:
Alzheimer's disease (AD) is a neurodegenerative disease characterized by a progressive decline in cognitive performance; Mild Cognitive Impairment (MCI) is instead an objective decline in cognitive performance that does not reach pathology. Paired immunoglobulin-like type 2 receptor alpha (PILRA) is a cell surface inhibitory receptor that was recently suggested to be involved in AD pathogenesis. In particular, the arginine-to-glycine substitution in position 78 (R78, rs1859788) was shown to be protective against AD.
Amino Acid Sequence:
Glu32-Val197
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.